Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
ABC trial (A011502): Randomized phase III double blinded placebo controlled trial of aspirin as adjuvant therapy for breast cancer. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I ...
Breast cancer patients who participated in a remote weight loss intervention program lost an average of 4.7% of their baseline body weight after one year, while those in the education only control ...
The BWEL trial showed significant weight loss in the WLI group, suggesting potential benefits in reducing cancer recurrence and mortality. The trial involved 3180 women with stage II/III HER2-negative ...
**NM signifies a non meaningful value. A dash signifies the data is not available.
Obesity has many adverse effects in patients with breast and other cancers. In this analysis, breast cancer patients randomized to a behavioral weight-loss intervention lost an average of 4.7% of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results